Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
Journal of Nanobiotechnology volume 20, Article number: 234 (2022)
Correction to: Journal of Nanobiotechnology (2022) 20:129 https://doi.org/10.1186/s12951-022–01322-y
Following publication of the original article , the author reported that the corresponding author symbols were omitted from the author group. Dr. Jianfeng Cai and Peipei Xu have been added to the author group and are presented correctly in this correction article. There are 3 corresponding authors, including Ms. Yong Hu (firstname.lastname@example.org), Jianfeng Cai (email@example.com) and Peipei Xu (firstname.lastname@example.org).
The original article  has been corrected.
Jiang W, Wei L, Chen B, Luo X, Xu P, Cai J, Hu Y. Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy. J Nanobiotechnol. 2022;20:129. https://doi.org/10.1186/s12951-022-01322-y.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Jiang, W., Wei, L., Chen, B. et al. Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy. J Nanobiotechnol 20, 234 (2022). https://doi.org/10.1186/s12951-022-01418-5